Close-up of samples pipetting in petri dish for cell experiment at laboratory
ARTICLE
Q&A: Investing in the ongoing revolution in life sciences
Advances in life sciences are remaking our understanding of illness and disease. As the sector faces challenges, alternative strategies like private capital and royalty monetization are gaining importance.

Insights

The latest from Blue Owl: articles, podcasts, whitepapers, and more.

May 27, 2025
Article

Investing in the ongoing revolution in life sciences

Learn more
May 13, 2025
Article

The growth and durability of software lending

Learn more
April 30, 2025
Article

Investing in real assets in a volatile market

Learn more
April 22, 2025
Article

Private markets and the value of stability

Learn more
April 10, 2025
Article

Skyrocketing data center growth drives massive investment

Learn more
February 21, 2025
White Paper

Assessing ESG factors in GP Stakes investing

Learn more
February 10, 2025
White Paper

US Consumer vs. Corporate Risk: A case in misperception

Learn more
January 15, 2025
Market Commentary

2025 Market Outlook

Learn more
January 14, 2025
White Paper

Navigating the credit markets

Learn more
December 16, 2024
White Paper

The anatomy of a GP stakes fund: an investment for all seasons

Learn more
July 19, 2024
Sustainability Report

From plans to progress: 2023 Sustainability Report

Learn more
April 30, 2024
White Paper

The opportunity in the US onshoring movement

Learn more